Immunotherapy combined with chemotherapy versus chemotherapy alone as the first‐line treatment of PD‐L1‐negative and driver‐gene‐negative advanced nonsquamous non‐small‐cell lung cancer: An updated systematic review and meta‐analysis

BACKGROUND: This meta‐analysis aimed to compare the efficacy of immunotherapy combined with chemotherapy versus chemotherapy alone as the first‐line therapy for patients with programmed death ligand‐1 (PD‐L1)‐negative and driver‐gene‐negative advanced nonsquamous non‐small‐cell lung cancer (NSCLC)....

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Yue, Wu, Xinyu, Zou, Yifeng, Zhang, Xue, Bai, Hua, Dong, Mei, Duan, Jianchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663683/
https://www.ncbi.nlm.nih.gov/pubmed/36168110
http://dx.doi.org/10.1111/1759-7714.14664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663683/
https://www.ncbi.nlm.nih.gov/pubmed/36168110
http://dx.doi.org/10.1111/1759-7714.14664

Ejemplares similares